Escitalopram: a pharmacoeconomic review of its use in depression.
about
Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium.Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression.
P2860
Escitalopram: a pharmacoeconomic review of its use in depression.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Escitalopram: a pharmacoeconomic review of its use in depression.
@ast
Escitalopram: a pharmacoeconomic review of its use in depression.
@en
Escitalopram: a pharmacoeconomic review of its use in depression.
@nl
type
label
Escitalopram: a pharmacoeconomic review of its use in depression.
@ast
Escitalopram: a pharmacoeconomic review of its use in depression.
@en
Escitalopram: a pharmacoeconomic review of its use in depression.
@nl
prefLabel
Escitalopram: a pharmacoeconomic review of its use in depression.
@ast
Escitalopram: a pharmacoeconomic review of its use in depression.
@en
Escitalopram: a pharmacoeconomic review of its use in depression.
@nl
P1433
P1476
Escitalopram: a pharmacoeconomic review of its use in depression.
@en
P2093
Katherine F Croom
P304
P356
10.2165/00019053-200321160-00004
P577
2003-01-01T00:00:00Z
P6179
1044170807